Minnesota Medicaid and semaglutide
Wegovy for weight loss: yes. Prior authorization. Adults: BMI 30 or higher, or BMI 27 or higher with a weight-related condition. Ages 12 to 17: BMI 30 or higher and body weight above 60 kg. Diet and activity documentation; at least 5% weight loss to renew. Ozempic for weight loss: not confirmed. The May 2026 Uniform PDL lists Ozempic under hypoglycemics, which does not answer weight loss. The anti-obesity list does not name it, and absence is not a no. No Ozempic-specific criteria could be read; other mn.gov criteria pages returned a bot check.; for type 2 diabetes Minnesota Medicaid must cover it. Read from Minnesota Department of Human Services documents Nov 6, 2026.
In 2025 Minnesota Medicaid paid for 165,896 semaglutide prescriptions (Wegovy, Ozempic, Rybelsus), 72% of its GLP-1 prescriptions and 7th of the 50 states and DC. It reimbursed $191.8 million before rebates, $1,156 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Wegovy | 90,988 | $118.7 million | $1,305 |
| Ozempic | 73,428 | $71.5 million | $973 |
| Rybelsus | 1,480 | $1.6 million | $1,084 |
Minnesota plans and prescribing rules
Minnesota Advantage Health Plan (SEGIP). Minnesota's Advantage Health Plan, in its 2026 Summary of Benefits, excludes weight-loss drugs unless they are medically necessary, appropriate treatment and part of a Plan-approved program.
Semaglutide in the states around Minnesota
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Minnesota | 19 | $39/moWellmedr | 165,896 | Medicaid Wegovy: Yes |
| Iowa | 19 | $39/moWellmedr | 53,645 | Medicaid Wegovy: No |
| North Dakota | 17 | $39/moWellmedr | 1,627 | Medicaid Wegovy: No |
| South Dakota | 19 | $39/moWellmedr | 7,210 | Medicaid Wegovy: No |
| Wisconsin | 19 | $39/moWellmedr | 87,468 | Medicaid Wegovy: No |



